Atlas Trials

Other Protocol Specified Criteria

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Other Protocol Specified Criteria

RecordFirmDate
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors (NCT06128148)Guangzhou JOYO Pharma Co., Ltd2022-05-04

Track Other Protocol Specified Criteria automatically

Every clearance here is in the API, with alerts when new ones post.